Kayano Hidekazu
School of Medical Technology, Faculty of Health and Medical Care, Saitama Medical University.
Rinsho Ketsueki. 2018;59(10):2084-2088. doi: 10.11406/rinketsu.59.2084.
Myelodysplastic syndromes/myeloproliferative neoplasm (MDS/MPN) is a type of myeloid neoplasm where at least one hematopoietic lineage exhibiting cytopenia clinically coexists with other (s) exhibiting hypercytosis. There is ineffective erythropoiesis and bone marrow coexistence of at least one hematopoietic lineage morphologically characterized by dysplasia of blood cells and other (s) characterized by pronounced proliferation. At a molecular level, various abnormalities have been identified that overlap with related diseases, and a prerequisite for MDS/MPN diagnosis includes ruling out various hematopoietic tumors and reactive conditions. Therefore, a multilateral approach involving clinical findings, morphology, and molecular biology is needed. Herein, we introduce the pathological features of MDS/MPN and the relationship between molecular abnormalities and morphological characteristics.
骨髓增生异常综合征/骨髓增殖性肿瘤(MDS/MPN)是一种髓系肿瘤,其中至少一种造血谱系临床上表现为血细胞减少,同时其他造血谱系表现为血细胞增多。存在无效红细胞生成,骨髓中至少一种造血谱系在形态学上以血细胞发育异常为特征,其他造血谱系以显著增殖为特征。在分子水平上,已发现各种与相关疾病重叠的异常,MDS/MPN诊断的一个先决条件包括排除各种造血肿瘤和反应性疾病。因此,需要一种涉及临床发现、形态学和分子生物学的多边方法。在此,我们介绍MDS/MPN的病理特征以及分子异常与形态学特征之间的关系。